Cardiovascular and metabolic effects of obesity

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 4, 2008, Pages 416-419

  Morris, Margaret J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Fetal programming; Hypertension; Intrauterine; Leptin; Obesity; Vascular

Indexed keywords

ADRENERGIC STIMULATION; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR FUNCTION; CONFERENCE PAPER; DISEASE MARKER; EPIGENETICS; HORMONAL REGULATION; HUMAN; HYPERTENSION; INCIDENCE; INFLAMMATION; LIFESTYLE; MALNUTRITION; MATERNAL NUTRITION; METABOLISM; NONHUMAN; OBESITY; OVERNUTRITION; PROGENY; PROTEIN RESTRICTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SYMPATHETIC TONE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; CARDIOVASCULAR DISEASES; ENERGY METABOLISM; HUMANS; HYPERTENSION; OBESITY;

EID: 40149107439     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.04912.x     Document Type: Conference Paper

References (60)

1. Access Economics. The economic costs of obesity. Report to Diabetes Australia. Access Economics, Canberra. 2006.
2. World Health Organization. Obesity and overweight (online). http://www.who.int/dietphysicalactivity/publications/facts/obesity/en/print/ html.
3. Batch JA, Baur LA. Management and prevention of obesity and its complications in children and adolescents. Med. J. Aust. 2005 182 : 130 5.
4. Booth ML, Wake M, Armstrong T et al. The epidemiology of overweight and obesity among Australian children and adolescents, 1995-97. Aust. N. Z. J. Public Health 2001 25 : 162 9.
5. Wells JC. The evolution of human fatness and susceptibility to obesity: An ethological approach. Biol. Rev. Camb. Philos. Soc. 2006 81 : 183 205.
6. Rankinen T, Zuberi A, Chagnon YC et al. The human obesity gene map: The 2005 update. Obesity (Silver Spring) 2006 14 : 529 644.
7. Redon J. Hypertension in obesity. Nutr. Metab. Cardiovasc. Dis. 2001 11 : 344 53.
8. Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: Role of leptin and sympathetic nervous system. Am. J. Hypertens. 2001 14 : 103S 15S.
9. Poirier P, Giles TD, Bray GA et al. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006 113 : 898 918.
10. Scholze J, Grimm E, Herrmann D, Unger T, Kintscher U. Optimal treatment of obesity-related hypertension. The hypertension-obesity-sibutramine (HOS) study. Circulation 2007 115 : 1991 8.
11. Batsis JA, Romero-Corral A, Collazo-Clavell ML et al. Effect of weight loss on predicted cardiovascular risk: Change in cardiac risk after bariatric surgery. Obesity 2007 15 : 772 84.
12. Grassi G, Quarti-Trevano F, Seravalle G, Dell'Oro R. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome. Nutr. Metab. Cardiovasc. Dis. 2007 17 : 473 81.
13. Rumantir MS, Vaz M, Jennings GL et al. Neural mechanisms in human obesity-related hypertension. J. Hypertens. 1999 17 : 1125 33.
14. Gentile CL, Orr JS, Davy BM, Davy KP. Modest weight gain is associated with sympathetic neural activation in nonobese humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007 292 : R1834 8.
15. Landsberg L, Young JB. Fasting, feeding and regulation of the sympathetic nervous system. N. Engl. J. Med. 1978 298 : 1295 301.
16. Goldstein DS. Plasma catecholamines and essential hypertension. An analytical review. Hypertension 1983 5 : 86 99.
17. Esler M, Lambert G, Jennings G. Noradrenaline release and the pathophysiology of primary human hypertension Am. J. Hypertens. 1989 2 : 140 6S.
18. Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler MD, Nestel PJ. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J. Clin. Endocrinol. Metab. 2005 90 : 5998 6005.
19. Shibao C, Gamboa A, Deidrich A et al. Autonomic contribution to blood pressure and metabolism in obesity. Hypertension 2007 49 : 27 33.
20. Stocker SD, Meador R, Adams JM. Neurons of the rostral ventrolateral medulla contribute to obesity-induced hypertension in rats. Hypertension 2007 49 : 640 6.
21. Aneja A, El-Atat F, McFarlane SI, Sowers JR. Hypertension and obesity. Recent Prog. Horm. Res. 2004 59 : 169 205.
22. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivits WI. Receptor-mediated regional sympathetic nerve activation by leptin. J. Clin. Invest. 1997 100 : 270 8.
23. Sierra-Johnson J, Romero-Corral A, Lopez-Jimenez F et al. Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population. Am. J. Cardiol. 2007 100 : 234 9.
24. Yamauchi T, Kamon J, Waki H et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 2001 7 : 941 6.
25. Yang WS, Lee WJ, Funahashi T et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J. Clin. Endocrinol. Metab. 2001 86 : 3815 19.
26. Ouchi N, Ohishi M, Kihara S et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003 42 : 231 4.
27. Hara K, Yanauchi T, Imai Y, Manabe I, Nagai R, Kadowaki T. Reduced adiponectin level is associated with severity of coronary artery disease. Int. Heart J. 2007 48 : 149 53.
28. Fésüs G, Dubrovska G, Gorzelniak K et al. Adiponectin is a novel humoral vasodilator. Cardiovasc. Res. 2007 75 : 719 27.
29. Ahmed SB, Fisher NDL, Stevanovic R, Hollenberg NK. Body mass index and angiotensin-dependent control of the renal circulation in healthy humans. Hypertension 2005 46 : 1316 20.
30. Stepp DW, Frisbee JC. Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats. Am. J. Physiol. Heart Circ. Physiol. 2002 282 : H816 20.
31. Jonk AM, Houben AJ, de Jongh RT, Serne EH, Schaper NC, Stehouwer CD. Microvascular dysfunction in obesity: A potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Physiology 2007 22 : 252 60.
32. Katakam PV, Tulbert CD, Snipes JA, Erdos B, Miller AW, Busija DW. Impaired insulin-induced vasodilation in small coronary arteries of Zucker obese rats is mediated by reactive oxygen species. Am. J. Physiol. Heart Circ. Physiol. 2005 288 : H854 60.
33. Eringa EC, Stehouwer CD, Roos MH, Westerhof N, Sipkema P. Selective resistance to vasoactive effects of insulin in muscle resistance arteries of obese Zucker (fa/fa) rats. Am. J. Physiol. Endocrinol. Metab. 2007 293 : E1134 9.
34. Hayashi K, Kanda T, Homma K. Altered renal microvascular responses in Zucker obese rats. Metabolism 2002 51 : 1553 61.
35. Rattigan S, Bussey CT, Ross RM, Richards SM. Obesity, insulin resistance, and capillary recruitment. Microcirculation 2007 14 : 299 309.
36. Hansen MJ, Jovanovska V, Morris MJ. Adaptive responses in hypothalamic neuropeptide Y in the face of prolonged high fat feeding in the rat. J. Neurochem. 2004 88 : 909 16.
37. Morris MJ, Velkoska E, Cole TJ. Central and peripheral contributions to obesity associated hypertension: Impact of early overnourishment. Exp. Physiol. 2005 90 : 697 702.
38. Velkoska ETJ, Cole Morris MJ. Early dietary intervention: Long-term effects on blood pressure, brain neuropeptide Y, and adiposity markers. Am. J. Physiol. Endocrinol. Metab. 2005 288 : E1236 43.
39. Haddock R. The mechanism of EDH-dependent vasodilator acivity is altered in diet-induced obese rat mesenteric artery. Proc. Aust. N. Z. Microcirc. Soc. 2007 (abstract).
40. Oltman CL, Kleinschmidt TL, Coppey LJ, Davidson EP, Yorek MA. Coronary and mesenteric vascular dysfunction in high fat fed rats. Microcirculation 2007 14 : 498.
41. Magarey AM, Daniels LA, Boulton TJ, Cockington RA. Predicting obesity in early adulthood from childhood and parental obesity. Int. J. Obes. Relat. Metab. Disord. 2003 27 : 505 13.
42. Lake JK, Power C, Cole TJ. Child to adult body mass index in the 1958 British birth cohort: Associations with parental obesity. Arch. Dis. Child 1997 77 : 376 81.
43. Wu Q, Suzuki M. Parental obesity and overweight affect the body-fat accumulation in the offspring: The possible effect of a high-fat diet through epigenetic inheritance. Obes. Rev. 2006 7 : 201 8.
44. Martorell R, Stein AD, Schroeder DG. Early nutrition and later adiposity. J. Nutr. 2001 131 : 874S 80S.
45. Power C, Elliott J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int. J. Epidemiol. 2006 35 : 34 41.
46. Barker DJ. The fetal and infant origins of disease. Eur. J. Clin. Invest. 1995 25 : 457 63.
47. Krechowec SO, Vickers M, Gertler A, Breier BH. Prenatal influences on leptin sensitivity and susceptibility to diet-induced obesity. J. Endocrinol. 2006 189 : 355 63.
48. Cottrell EC, Ozanne SE. Developmental programming of energy balance and the metabolic syndrome. Proc. Nut. Soc. 2007 66 : 198 206.
49. Levin BE. The obesity epidemic: Metabolic imprinting on genetically susceptible neural circuits. Obes. Res. 2000 8 : 342 7.
50. Bouret SG, Draper SJ, Simerly RB. Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 2004 304 : 108 10.
51. Yeh J, Shelton JA. Increasing prepregnancy body mass index: Analysis of trends and contributing variables. Am. J. Obest. Gynecol. 2005 193 : 1994 8.
52. Srinivasan M, Aalinkeel R, Song F et al. Maternal hyperinsulinemia predisposes rat fetuses for hyperinsulinemia and adult-onset obesity and maternal mild food restriction reverses this phenotype. Am. J. Physiol. Endocrinol. Metab. 2006 290 : E129 34.
53. Parsons TJ, Power C, Manor O. Fetal and early life growth and body mass index from birth to early adulthood in 1958 British cohort: Longitudinal study. Br. Med. J. 2001 323 : 1320 1.
54. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: Association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005 115 : e290 6.
55. Khan IY, Taylor PD, Dekou V et al. Gender-linked hypertension in offspring of lard-fed pregnant rats. Hypertension 2003 41 : 168 75.
56. Khan IY, Dekou V, Douglas G et al. A high-fat diet during rat pregnancy or suckling induces cardiovascular dysfunction in adult offspring. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005 288 : R127 33.
57. Armitage JA, Lakasing L, Taylor PD et al. Developmental programming of aortic and renal structure in offspring of rats fed fat-rich diets in pregnancy. J. Physiol. 2005 565 : 171 84.
58. Mohankumar SM, King A, Shin AC, Sirivelu MP, Mohankumar PS, Fink GD. Developmental programming of cardiovascular disorders: Focus on hypertension. Rev. Endocr. Metab. Disord. 2007 8 : 115 25.
59. Moritz KM, Johnson K, Douglas-Denton R, Wintour EM, Dodic M. Maternal glucocortocoid treatment programs alterations in the renin-angiotensin system of the ovine fetal kidney. Endocrinology 2002 143 : 4455 63.
60. Bogdarina I, Welham S, King PJ, Burns SP, Clark AJ. Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circ. Res. 2007 100 : 520 6.